Approximately 500 putative proteases have been identified in human genome. Through controlling complex proteolytic activities, proteases participate in a wide range of physiological processes. Many of them have been utilized as targets for therapeutic intervention, such as Dipeptidyl Peptidase IV (DPP-IV) and HIV-1 protease for diabetes and AIDS, respectively. However, precise roles of many proteases remain unknown in many diseases. To speed up the drug discovery process that involves protease targets, Creative BioMart has developed a protease assay panel for protease screening and profiling. Moreover, custom assay development service is available to facilitate your drug screening against protease targets of your interest.
Creative BioMart has assembled the largest protease panel in industry which covers over 70 proteases. Our comprehensive protease panel profiling will boost your capability in evaluating structure-activity relationship in drug development process and minimize the risks in overall clinical stage.
Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.